Oklahoma § 63-2-803 Approved cannabidiol for use in clinical trials.

Oklahoma Statutes

§ 63-2-803 — Approved cannabidiol for use in clinical trials.

Oklahoma § 63-2-803

Title 63Public Health And Safety

This text of Oklahoma § 63-2-803 (Approved cannabidiol for use in clinical trials.) is published on Counsel Stack Legal Research, covering Oklahoma primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Okla. Stat. tit. 63, § 63-2-803 (2026).

Text

A.Clinical trials conducted pursuant to a statewide investigational new drug application established pursuant to the provisions of this act shall only utilize cannabidiol which is: 1. From an approved source; and 2. Approved by the United States Food and Drug Administration to be used for treatment of a condition specified in an investigational new drug application.

B.The principal investigator and any subinvestigator may receive cannabidiol directly from an approved source or authorized distributor for an approved source for use in the clinical trials.

Free access — add to your briefcase to read the full text and ask questions with AI

A. Clinical trials conducted pursuant to a statewide investigational new drug application established pursuant to the provisions of this act shall only utilize cannabidiol which is: 1. From an approved source; and 2. Approved by the United States Food and Drug Administration to be used for treatment of a condition specified in an investigational new drug application. B. The principal investigator and any subinvestigator may receive cannabidiol directly from an approved source or authorized distributor for an approved source for use in the clinical trials.